Br Med J (Clin Res Ed)  1982;285:537-540 (21 August), doi:10.1136/bmj.285.6341.537

Randomised controlled trial of nicotine chewing-gum.

M J Jarvis, M Raw, M A Russell, C Feyerabend

The effectiveness of 2 mg nicotine chewing-gum as an aid to stopping smoking was compared with a placebo containing 1 mg nicotine, but unbuffered, in a double-blind randomised trial. Of 58 subjects given the active gum, 27 (47%) were not smoking at one-year follow-up compared with 12 (21%) of the 58 subjects treated with placebo (p less than 0.025). By the most stringent criterion of outcome, 18 (31%) subjects in the active treatment group and eight (14%) in the placebo group had not smoked at all from the start of treatment to follow-up at one year (p less than 0.05). Subjects receiving the active gum experienced less severe withdrawal symptoms and rated their gum as more helpful than did the placebo group. Minor side effects were common but only gastric symptoms were more frequent with the active gum. Subjects receiving active gum used it for longer than those receiving placebo but most stopped using it within six months and only four (7%) developed longer-term dependence. The number of gums used daily correlated significantly with pretreatment blood nicotine concentrations in the active treatment group and with pretreatment cigarette consumption in the placebo group. A lower pretreatment blood nicotine value was the best predictor of success at one year (p less than 0.001) but there was no significant relation to cigarette consumption, sex, and social class. The results clearly confirm the usefulness of nicotine chewing-gum as an aid to stopping smoking and imply a definite role for nicotine in cigarette dependence and withdrawal. Successful use of the gum requires careful attention to subjects' expectations and clear instructions on how to use it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Stapleton, J. (1998). Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res 7: 187-203 [Abstract]  
  • Hjalmarson, A., Nilsson, F., Sjostrom, L., Wiklund, O. (1997). The Nicotine Inhaler in Smoking Cessation. Arch Intern Med 157: 1721-1728 [Abstract]  
  • Fiscella, K., Franks, P. (1996). Cost-effectiveness of the Transdermal Nicotine Patch as an Adjunct to Physicians' Smoking Cessation Counseling. JAMA 275: 1247-1251 [Abstract]  
  • Sachs, D. P. L. (1995). Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers. Arch Intern Med 155: 1973-1980 [Abstract]  
  • Hjalmarson, A., Franzon, M., Westin, A., Wiklund, O. (1994). Effect of Nicotine Nasal Spray on Smoking Cessation: A Randomized, Placebo-Controlled, Double-blind Study. Arch Intern Med 154: 2567-2572 [Abstract]  
  • Cummings, K. M., Biernbaum, R. M., Zevon, M. A., Deloughry, T., Jaen, C. R. (1994). Use and Effectiveness of Transdermal Nicotine in Primary Care Settings. Arch Fam Med 3: 682-689 [Abstract]  
  • Lee, E. W., D'Alonzo, G. E. (1993). Cigarette Smoking, Nicotine Addiction, and Its Pharmacologic Treatment. Arch Intern Med 153: 34-48 [Abstract]  
  • Hughes, J. R., Gust, S. W., Keenan, R., Fenwick, J. W., Skoog, K., Higgins, S. T. (1991). Long-term Use of Nicotine vs Placebo Gum. Arch Intern Med 151: 1993-1998 [Abstract]  
  • Daughton, D. M., Heatley, S. A., Prendergast, J. J., Causey, D., Knowles, M., Rolf, C. N., Cheney, R. A., Hatlelid, K., Thompson, A. B., Rennard, S. I. (1991). Effect of Transdermal Nicotine Delivery as an Adjunct to Low-Intervention Smoking Cessation Therapy: A Randomized, Placebo-Controlled, Double-blind Study. Arch Intern Med 151: 749-752 [Abstract]  
  • Blondal, T. (1989). Controlled Trial of Nicotine Polacrilex Gum With Supportive Measures. Arch Intern Med 149: 1818-1821 [Abstract]  
  • Fortmann, S. P., Killen, J. D., Telch, M. J., Newman, B. (1988). Minimal Contact Treatment for Smoking Cessation: A Placebo Controlled Trial of Nicotine Polacrilex and Self-directed Relapse Prevention: Initial Results of the Stanford Stop Smoking Project. JAMA 260: 1575-1580 [Abstract]  
  • Hajek, P., Jackson, P., Belcher, M. (1988). Long-term Use of Nicotine Chewing Gum: Occurrence, Determinants, and Effect on Weight Gain. JAMA 260: 1593-1596 [Abstract]  
  • Russell, M. A. H., Jarvis, M. J., Sutherland, G., Feyerabend, C. (1987). Nicotine Replacement in Smoking Cessation: Absorption of Nicotine Vapor From Smoke-Free Cigarettes. JAMA 257: 3262-3265 [Abstract]  
  • West, R. J. (1986). Dependence on Nicotine Chewing Gum. JAMA 256: 3214-3215 [Abstract]  
  • Oster, G., Huse, D. M., Delea, T. E., Colditz, G. A. (1986). Cost-effectiveness of Nicotine Gum as an Adjunct to Physician's Advice Against Cigarette Smoking. JAMA 256: 1315-1318 [Abstract]  
  • Olson, B.L., McDonald, J.L. Jr, Gleason, M.J., Stookey, G.K., Schemehorn, B.R., Drook, C.A., Beiswanger, B.B., Christen, A.G. (1985). Comparisons of Various Salivary Parameters in Smokers Before and After the Use of a Nicotine-containing Chewing Gum. JDR 64: 826-830 [Abstract]  
  • Hjalmarson, A. I. M. (1984). Effect of Nicotine Chewing Gum in Smoking Cessation: A Randomized, Placebo-Controlled, Double-blind Study. JAMA 252: 2835-2838 [Abstract]  
  • Hughes, J. R., Miller, S. A. (1984). Nicotine Gum to Help Stop Smoking. JAMA 252: 2855-2858 [Abstract]  
  • JOHNSON, R. W., LEVINE, D. (1984). Nicotine Chewing Gum. ANN INTERN MED 101: 566-566 [Abstract]  
  • Ebert, R. V., McNabb, M. E. (1984). Cessation of Smoking in Prevention and Treatment of Cardiac and Pulmonary Disease. Arch Intern Med 144: 1558-1559 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ